DRI-STEEM Models GTS® and GTS-DI - dristeem 405725
Assessing for a product is not a bladder/bowel assessment. It is only a part of a wider comprehensive assessment. Products can improve a patient’s quality of life, protect dignity and encourage functional and social independence when recovery of bladder/bowel function is not possible.
NB: Prescriber should be aware of contra indications and note that Antimuscarinic drugs should be used with caution in older people (especially if frail).
He presents not having passed a good volume of urine for approx 48 hrs, he appears to continuously dribble small amounts of urine. Robert has had two episodes of faecal incontinence passing very loose foul smelling stool, it is unclear when he last had a normal formed bowel motion.
It is vital that before supplying a patient with a containment product, clear instructions about the correct use, fitting, storage and disposal of the product are given.
Medications: Fybogel™, furosemide, nifedipine, metformin and amitriptyline (for more information on each of these medications see “Additional Information”).
Mr Robert Smith is a 73 year old gentleman. He is admitted to your ward with a profound right sided weakness. He is immobile and requires a hoist for all transfers. He has expressive dysphasia and on admission appears very confused and agitated.
Following assessment and post void Bladder Scan you establish that there is a residual volume of approx. 350mls of urine in his bladder.
Neil
Neil